FUNDAMENTALS
EdgeFII/DII
FORTISFortis Healthcare
₹825.00+1.87%
Terminal
  • Overview
  • Price
  • Ratios
  • About
  • P&L
  • Balance
  • Cash flow
  • Holders
  • Actions
  • Peers
  • News
FORTISNSE · EquityHealthcare Services

Fortis Healthcare

ISIN
INE061F01013
Instrument key
NSE_EQ|INE061F01013
Open in terminal Fundamentals cached for 6 hours
Last traded price
₹825.00+15.15 · +1.87%
Day rangecircuit ₹742.50 – ₹907.50
802.40
829.00

as of 21/11/2026, 1:51:06 pm

Open
₹804.00
Day high
₹829.00
Day low
₹802.40
Prev. close
₹809.85
Volume
22.88 L
VWAP
₹821.48

On this page

Company

  • Overview
  • Price chart
  • Key ratios
  • About

Statements

  • Profit & loss
  • Balance sheet
  • Cash flow

Ownership

  • Shareholding
  • Corporate actions
  • Peers

Market

  • News

02/Price history

Price chart

1 month · 30-minute candles. Hover the chart for the OHLC of any candle; the table below holds the same data row by row.

1D1W1M6M1Y5YMAX
Change · 1M
+15.21%
716.10 → 825.00
Period high
₹829.00
20/11/2026
Period low
₹704.95
23/10/2026
From high
-0.48%
+17.03% from low
Avg volume
1.15 L
3.17 Cr total
Candles
276
143 up / 130 down
20 Nov 2026O 822.40H 825.00L 822.40C 825.00Vol 23.0K
SMA 20SMA 50Averages need 50 candles before they begin
Candle data276 rows of open, high, low, close and volumeShowHide
20 Nov 2026822.40825.00822.40825.00+0.32%2.6023.0K
20 Nov 2026822.35825.40820.25822.40+0.01%5.152.97 L
20 Nov 2026821.05824.00820.00822.50+0.18%4.001.92 L
20 Nov 2026820.80822.55820.05821.30+0.06%2.501.29 L
20 Nov 2026821.85823.50820.50821.20-0.08%3.001.24 L
20 Nov 2026818.60824.00818.20822.50+0.48%5.801.81 L
20 Nov 2026816.05819.50816.05818.20+0.26%3.4537.9K
20 Nov 2026813.10817.25812.20816.05+0.36%5.0559.3K
20 Nov 2026818.90820.00812.20813.50-0.66%7.801.48 L
20 Nov 2026822.00822.15817.30819.05-0.36%4.851.56 L

Historical price and volume data · Showing 1–10 of 276

1 / 28

03/Valuation & returns

Key ratios vs sector

Company value benchmarked against the sector median. The ratio set is sector specific — banks report NIM, CASA and Net NPA instead of EV/EBITDA.

P/E

Price ÷ earnings per share

58.64
Company
58.64
Sector
55.28

Worse than sector by 6%

P/B

Price ÷ book value per share

5.94
Company
5.94
Sector
3.05

Worse than sector by 95%

ROA

Net income ÷ total assets

6.47%
Company
6.47%
Sector
4.2%

Better than sector by 54%

ROE

Net income ÷ shareholders' equity

9.91%
Company
9.91%
Sector
-31.98%

Better than sector by 131%

ROCE

EBIT ÷ capital employed

12.56%
Company
12.56%
Sector
11.89%

Better than sector by 6%

Quick Ratio

Liquid assets ÷ current liabilities

0.8
Company
0.8
Sector
32.98

Worse than sector by 98%

EV/EBITDA

Enterprise value ÷ EBITDA

28.99
Company
28.99
Sector
23.22

Worse than sector by 25%

04/Business

About the company

Sector: Healthcare Services

Fortis Healthcare Limited is an India-based integrated healthcare service provider. The Company is primarily engaged in the business of healthcare services. Its segment includes the Healthcare business and the Diagnostics business. The healthcare business includes inpatient and outpatient services, sale of medical and nonmedical items and management fees from hospitals. The diagnostic business includes pathology and radiology services. Its specialties include cardiac sciences, cosmetology, dental sciences, dermatology, general surgery, oncology, urology, neurosurgery, radiology, orthopedics, and organ transplant, among others. The healthcare verticals of the Company primarily consist of day care specialty, diagnostics and tertiary and quaternary care. The Company has approximately 28 healthcare facilities, including projects under development, 4500 operational beds and over 400 diagnostics centers. It operates in India, the United Arab Emirates, Nepal, and Sri Lanka.

Sector market cap (INR)
₹62,284 Cr

reported in crore

Sector market cap (USD)
$6.92B

reported in billion

Market capitalisation is reported at the sector-constituent level, not the standalone company level.

05/Profit & loss

Standalone income statement

Annual figures in ₹ crore. Growth marked reported is provided; margins are derived.

YearlyQuarterly
ConsolidatedStandalone
Revenue · Mar 2026
₹1,958 Cr
+19.05% vs Mar 2025
Net profit · Mar 2026
₹230 Cr
+261.09% vs Mar 2025
Operating margin
13.8%
was 7.0%
Revenue CAGR · 4p
17.6%
profit 33.8% · op 35.3%
Filed order
Revenue1,9581,6441,3241,203
Revenue growthreported19.1%24.2%10.1%—
Operating profit269114247109
Operating profit growthreported135.5%-53.6%126.5%—
Operating marginderived13.8%7.0%18.6%9.1%
Net profit2306419996
Net profit growthreported261.1%-68.0%107.2%—
Net marginderived11.8%3.9%15.1%8.0%
EPS — basic₹/share, annual3.050.842.641.27

Figures in ₹ crore. Margin rows are computed from the reported values.

Full annual line itemsRevenue, other income, expenses, tax, EPSShowHide
Filed order
Revenue1,7931,4461,1811,053
Other Income165199143150
Total Revenue1,9581,6441,3241,203
Total Expenses1,7191,4151,1721,142
Profit Before Tax269114247109
Tax39514713
Profit After Tax2306419996
EPS - Basic3.050.842.641.27
EPS - Diluted3.050.842.641.27

This breakdown is available annually, even when the summary above is quarterly. EPS rows are per share.

06/Balance sheet

Standalone balance sheet

Only annual balance sheets are available — the quarterly filter does not apply here. Figures in ₹ crore; net worth is assets minus liabilities.

ConsolidatedStandalone
Total assets · Mar 2026
₹11,994 Cr
-0.04% YoY
Total liabilities
₹2,765 Cr
Net worth
₹9,229 Cr
Liabilities ÷ assets
23.1%
lower means a lighter balance sheet
Filed order
Total assets11,99411,99910,38710,369
Total liabilities2,7652,9251,3001,405
Net worthderived9,2299,0749,0878,964
Liabilities ÷ assetsderived23.1%24.4%12.5%13.6%
Asset growthderived-0.0%15.5%0.2%—

Figures in ₹ crore. Stacked chart height equals total assets.

Full annual line itemsNon-current & current assets, liabilities, equity capitalShowHide
Filed order
Non-Current Assets11,66111,6099,7459,679
Current Assets333390642690
Total Assets11,99411,99910,38710,369
Current Liabilities1,009995760757
Net Current Asset-676-605-119-67
Non-Current Liabilities1,7571,930540648
Equity Capital9,2299,0749,0878,964
Total Equity & Liabilities11,99411,99910,38710,369

Figures in ₹ crore unless the line item is per-share.

07/Cash flow

Standalone cash flow

Annual only, in ₹ crore. Negative values are outflows, so healthy companies usually show positive operating and negative investing cash flow.

ConsolidatedStandalone
Operating · Mar 2026
₹116 Cr
-65.23% YoY
Investing
₹11 Cr
Financing
-₹176 Cr
Free cash flow
₹127 Cr
operating + investing
Filed order
Operating activities116334218198
Operating changereported-65.2%52.9%10.1%—
Investing activities11-1,57244205
Investing changereported100.7%-3636.2%-78.3%—
Financing activities-1761,276-245-395
Financing changereported-113.8%620.0%38.0%—
Net cash flowderived-4938188
Free cash flowoperating + investing127-1,238263403

Figures in ₹ crore.

Full annual line itemsProfit before tax through closing cash balanceShowHide
Filed order
Profit before tax269114247109
Income before WC changes398264200136
Change in Assets-71-65-39-39
Change in Liabilities-10613481135
Change in WC-177684296
Cash flow from Operations116334218198
Cash flow from Investing11-1,57244205
Cash flow from Financing-1761,276-245-395
Total Cash Flow-4938188
Cash (Start of the year)435-12-20
Cash (End of the year)-6435-12

Figures in ₹ crore unless the line item is per-share.

08/Ownership

Shareholding pattern

Percentage of total shares by holder category across the last 4 reported quarters. Sort any quarter column to rank holders by size.

Promoters
31.17%
0.00 pts QoQ
FII
23.19%
-2.01 pts QoQ
DII (other)
7.52%
+1.09 pts QoQ
Mutual funds
26.94%
+1.13 pts QoQ
Retail & others
11.18%
-0.22 pts QoQ
Filed order
Promoters31.2%31.2%31.2%31.2%
FII23.2%25.2%26.0%27.8%
DII (other)7.5%6.4%5.6%5.1%
Mutual funds26.9%25.8%25.7%24.2%
Retail & others11.2%11.4%11.5%11.7%
Promoters — QoQ changepts, derived0.0%0.0%0.0%—
FII — QoQ changepts, derived-2.0%-0.8%-1.9%—
DII (other) — QoQ changepts, derived1.1%0.8%0.5%—
Mutual funds — QoQ changepts, derived1.1%0.1%1.5%—
Retail & others — QoQ changepts, derived-0.2%-0.1%-0.2%—
Totalderived100.0%100.0%100.0%100.0%

Values are percentages of total outstanding shares; QoQ rows are percentage-point moves.

09/Events

Corporate actions

Dividends, bonuses, splits and rights issues. Filter by type, sort by any date, and expand a row for the full event detail.

DividendFinal₹1.0010.0%24 Jul 202624 Jul 202622 May 2026

10/Comparison

Peers & competitors

Competitor set priced live. Filter by sector, sort any column, and expand a peer for its business description.

Sector
APOLLOHOSPApollo Hospitals Enter. LHealthcare Services₹9,200.00+5.29%14.13 L₹1,32,139 Cr$14.68B
MAXHEALTHMAX Healthcare INS LtdHealthcare Services₹1,081.00+3.88%95.32 L₹1,05,080 Cr$11.68B
MANIPALHOSManipal Health Enterpri LHealthcare₹702.20+0.83%11.62 L₹92,366 Cr$10.26B
ASTERDMAster DM Quality Care LtdHealthcare Services₹779.30+5.41%26.66 L₹67,960 Cr$7.55B
MEDANTAGlobal Health LimitedHealthcare Services₹1,480.20+0.13%2.65 L₹39,829 Cr$4.43B
NHNarayana Hrudayalaya Ltd.Healthcare Services₹1,945.00+3.84%7.85 L₹39,757 Cr$4.42B
LALPATHLABDR. LAL Path Labs Ltd.Healthcare Services₹1,989.00+1.31%2.65 L₹33,680 Cr$3.74B
KIMSKrishna Inst Of MED SCI LHealthcare Services₹795.60+3.62%10.44 L₹33,483 Cr$3.72B
SYNGENESyngene International LtdDiversified₹451.70+3.28%25.58 L₹18,240 Cr$2.03B
MOLBIOMolbio Diagnostics LtdHealthcare₹1,495.50-2.02%7.01 L₹17,228 Cr$1.91B

Market cap is the sector-constituent figure reported per peer · Showing 1–10 of 10

1 / 1

11/Coverage

Company news

Articles published in the last seven days, paginated by the provider.

5102050
  • Thumbnail: Max Healthcare, Apollo Hospitals, other healthcare stocks surge over 5% despite volatile market; what’s behind the surge?
    yesterday20/11/2026, 11:17:17 am
    Max Healthcare, Apollo Hospitals, other healthcare stocks surge over 5% despite volatile market; what’s behind the surge?

    Healthcare stocks like Apollo Hospitals and Max Healthcare, among others, were witnessing buying momentum in an overall volatile market on Friday, November 20, as investors focused on the constructive outlook despite the selling pressure from the global markets.

Showing 1–1 of 1 article